Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9884 |
EN523
|
Others | Others |
EN523 靶向 K48 泛素特异性去泛素酶 OTUB1 中的非催化变构半胱氨酸 C23。 | |||
T16333 |
NKY80
Adenylyl cyclase type V Inhibitor |
Adenylyl cyclase | Neuroscience |
NKY80 调节心脏和肺组织中的腺苷酸环化酶催化活性。 NKY80 是腺苷酸环化酶 V 型亚型的非竞争性抑制剂(IC50 值:V、III 和 II 型分别为 8.3 µM、132 µM 和 1.7 mM)。 | |||
T5461 |
GNE-6640
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
GNE 6640 是一种选择性泛素特异性肽酶 7(USP7)的非共价抑制剂,其对全长USP7、USP7 催化结构域、全长USP43 以及 Ub-MDM2 的IC50值分别为 0.75 μM、0.43 μM、20.3 μM 和 0.23 μM。 | |||
T11552 | hDDAH-1-IN-1 | Others | Others |
hDDAH-1-IN-1 is a selective non-amino acid catalytic site inhibitor of human dimethylarginine dimethylaminohydrolase-1 (hDDAH-1) (Ki: 18 μM). | |||
T12621L |
FT671
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
FT671 is a non-covalent and selective inhibitor of USP7 (IC50: 52 nM) It also binds to the USP7 catalytic domain (Kd: 65 nM). | |||
T11552L |
hDDAH-1-IN-1 TFA
|
Others | Others |
hDDAH-1-IN-1 TFA is a selective non-amino acid catalytic site inhibitor of human dimethylarginine dimethylaminohydrolase-1 (hDDAH-1) (Ki: 18 μM). | |||
T26827 |
Bisnorcymserine
N1 N8 Bisnorcymserine,N1N8Bisnorcymserine,N1-N8-Bisnorcymserine |
||
Bisnorcymserine is a reversible inhibitor of butyrylcholinesterase. The leaving group, bisnoreseroline, interacts in a non-covalent way with Ser(200) and His(440), disrupting the existing interactions within the catalytic triad, and it stacks with Trp(84) | |||
T13737 |
iRucaparib-AP6
|
Others; PROTACs | Others; PROTAC |
iRucaparib-AP6, a non-trapping PARP1 degrader, blocks both the catalytic activity and scaffolding effects of PARP1. iRucaparib-AP6 is a highly efficient and specific PARP1 degrader based on Rucaparib by using the PROTAC approach. | |||
T70810 |
THR-18
|
||
THR-18 is an 18-mer peptide derived from the sequence of human plasminogen activator inhibitor 1 (PAI-1), having the ability to bind to a site of tissue plasminogen activator (tPA) distal to its catalytic site and uncouple the beneficial clot-dissolving properties of tPA from its deleterious non-fibrinolytic effects. | |||
T76149 | Formate dehydrogenase | ||
Formate dehydrogenase 是一种普遍存在于原核生物和真核生物中的酶,能催化甲酸盐可逆氧化为二氧化碳。根据其金属含量、结构及催化策略,可将Formate dehydrogenase 分为非金属类和含金属类两种,广泛应用于生化研究领域。 | |||
T74638 |
XL01126
|
PROTACs | PROTAC |
XL01126是一种针对LRRK2的高效降解剂,其DC50值对G2019S LRRK2为14 nM,对WT LRRK2为32 nM。该化合物能穿透血脑屏障,作为帕金森疾病研究中的降解探针使用。同时,XL01126在LRRK2非催化功能和框架功能的研究上具有重要作用。 | |||
T82079 |
IGRP(206-214)
|
||
IGRP(206-214) 是一种肽,具有生物活性。它对应于非肥胖糖尿病型(NOD)小鼠中胰岛特异性葡萄糖6磷酸酶催化亚基相关蛋白(IGRP)的206-214残基,并能诱导此类小鼠产生糖尿病。此外,该肽对胰岛素原特异性T细胞有着特定的作用。 | |||
T74174 |
JB170
|
PROTACs | PROTAC |
JB170 是一种强效且高度特异性的PROTAC 介导的AURORA-A 降解剂 (DC50=28 nM),通过将 Alisertib 连接至Cereblon 配体 Thalidomide 而形成。JB170 优先结合 AURORA-A (EC50=193 nM) 而不是 AURORA-B (EC50=1.4µM)。JB170 介导的 S 期阻滞是由 AURORA-A 耗竭引起的。JB170 对 AURORA-A 激酶的非催化功能具有很好的抑制能力。 |